Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination IOP Lowering Therapy in Glaucoma and Ocular Hypertension
NCT00047541Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2001
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of travoprost + timolol in open-angle glaucoma (OAG) and ocular hypertension (3 arms), sponsored by Alcon Inc. Primary endpoint: Intraocular Pressure. Started Feb 2001; status: completed.
02
Drugs
travoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00047541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047541.